| Literature DB >> 31586495 |
Alice Watkins1,2, Stacey Bissell3, Jo Moss3,4, Chris Oliver3, Jill Clayton-Smith5, Lorraine Haye3, Mary Heald3, Alice Welham3,6.
Abstract
BACKGROUND: Pitt-Hopkins syndrome (PTHS) is a genetic neurodevelopmental disorder associated with intellectual disability. Although the genetic mechanisms underlying the disorder have been identified, description of its behavioural phenotype is in its infancy. In this study, reported behavioural and psychological characteristics of individuals with PTHS were investigated in comparison with the reported behaviour of age-matched individuals with Angelman syndrome (AS) and Cornelia de Lange syndrome (CdLS).Entities:
Keywords: Angelman syndrome; Autism spectrum disorder; Behavioural phenotype; Cornelia de Lange syndrome; Pitt-Hopkins syndrome
Year: 2019 PMID: 31586495 PMCID: PMC6778364 DOI: 10.1186/s11689-019-9282-0
Source DB: PubMed Journal: J Neurodev Disord ISSN: 1866-1947 Impact factor: 4.025
The genetic mechanism, estimated prevalence and suggested behavioural phenotypes of the comparison syndrome groups AS and CdLS
| Syndrome | Genetic mechanisms | Estimated prevalence | Behavioural phenotype |
|---|---|---|---|
| Pitt-Hopkins syndrome (PTHS) | Deletion of or variants in the TCF4 gene located at 18q21.2 that encodes transcription factor 4 [ | Estimated as 1 in 225,000 to 300,000 [ | ID, speech and language impairment, anxiety, self-injurious behaviour, aggression, repetitive behaviour and ASD [ |
| Angelman syndrome (AS) | Deficiency or disruption to the UBE3A gene located on chromosome 15. Approximately 70% of AS cases are caused by de novo maternal deletions at 15q11-q13 [ | Estimated at 1 in 20,000 in the population [ | Severe ID, speech, and language impairment, ataxic movement/movement or balance disorder (e.g. hypermotoric behaviour), enhanced laughter/smiling, happy demeanour, short attention spans and aggression [ |
| Cornelia de Lange syndrome (CdLS) | Heterozygous mutation of the NIPBL gene, located on chromosome 5p13 (approximately 65% of cases, with further cases being due to mosaicism). Less commonly caused by mutations in SMC3, SMC1A, HDAC8 and RED21 genes (11% of cases) [ | Estimated between 1 in 10,000 and 1 in 30,000 live births [ | ID, speech and language delay, self-injurious behaviour, autistic features, repetitive behaviours, aggression and hyperactivity [ |
Description and psychometric properties of assessments used
| Assessment [authors] | Description of assessment | Scoring | Psychometric properties |
|---|---|---|---|
| Wessex Questionnaire (WQ) [ | The questionnaire assesses ability in individuals with ID. The following subscales are assessed: continence, mobility, self-help skills, speech and literacy. Within the current study, “self-help” was used as a proxy measure to assess the degree of ability. | On the self-help subscale, individuals are rated on their ability to feed, wash and dress themselves. For each task, they are scored on a 3-point scale. The total self-help score ranges from 3 to 9: total score of 3–5 (“not able”), 6–7 (“partly able”) and 8–9 (“able”). | The scale has modest inter-rater reliability at subscale level for both children and adults ranging from 78% (self-help, literacy) to 92% (mobility) [ |
| Social Communication Questionnaire Lifetime Version (SCQ) [ | The parent-report questionnaire is used to measure ASD symptomatology and is a screening tool for ASD based on the Autism Diagnostic Interview. It consists of 40 items grouped into three subscales: communication, social interaction and repetitive and stereotyped behaviours. The lifetime version is completed in regards to an individual’s full developmental history. | The 40 items all require a yes/no response. Total scores range from 0 to 39. A cut-off score of > 15 indicates possible ASD and > 22 indicates possible autism. | The cut-off point of > 15 was found to distinguish pervasive developmental disorder (PDD) individuals from other diagnoses with a specificity of .80 and a sensitivity of .96 (excluding individuals with ID) and distinguished individuals with autism from people with ID with a specificity of .67 and sensitivity of .96. The higher cut-off of > 22 was necessary to distinguish between autism individuals with PDD with a specificity of .60 and a sensitivity of .75. The scale has good concurrent validity with the Autism Diagnostic Interview and with the Autism Diagnostic Observation Schedule [ |
| Sociability Questionnaire for people with Intellectual Disability (SQID) [ | The informant-based questionnaire assesses the sociability in children and adults and is appropriate for individuals with ID. The questionnaire contains 25 items including 13 categories and is to be completed regarding an individual’s typical behaviour across social situations with familiar and unfamiliar people and considers the possible indication of selective mutism. | The SQID consists of 25 items, 21 are on a 7-point scale (e.g. items 1–17: range from “very shy” to “very sociable”) and four are yes/no responses. Total scores evaluate the effect of social context on an individual’s sociability with a familiar or unfamiliar person. A higher score indicates more sociability. | The scale has a satisfactory inter-rater reliability for item level between .43 and .80 (Spearman’s coefficient > .60) for Q1-21. Kappa values for categorical items were .96, .44 and .51 (Q22, 24, 25). The scale also has good concurrent validity with the Child Sociability Rating Scale (CSRS [ |
| Challenging Behaviour Questionnaire (CBQ) [ | Part one of the questionnaire assesses the presence of self-injury, physical aggression, verbal aggression, destruction of property and stereotyped behaviour over the course of the previous month. Part two assesses the severity of each type of challenging behaviour. | Part one is based on a yes/no basis. Part two requires responses on a 4–5-point scale (14 items). Item scores are summed to provide an overall severity score. Lower scores indicate less severe behaviour. | The scale has good inter-rater reliability (range of |
| The Mood, Interest and Pleasure Questionnaire-Short Form (MIPQ) [ | The informant based questionnaire is appropriate for use for individuals with ID and assesses two main subscales of mood and interest and pleasure. | The short form consists of 12 items (6 items for each subscale). Items are rated on a 5-point scale, and total scores range between 0 and 48. A higher score indicates positive affect and higher levels of interest and pleasure. | The short form version of the MIPQ has good internal consistency ( |
| Repetitive Behaviour Questionnaire (RBQ) [ | The informant-based questionnaire is appropriate for use for children and adults with ID and examines the frequency of repetitive behaviours over the last month. The scale consists of 19 items including five subscales: stereotyped behaviour, compulsive behaviour, insistence on sameness, restricted preferences and repetitive speech. | Informants rate the frequency of each behaviour over the last month. Scores are rated on a 5-point scale from “never” (0) to “more than once a day” (5). A verbal score ranges between 0 and 76 and a nonverbal score ranges between 0 and 60 (4 items are only applicable to verbal individuals). Behaviours occurring “once a day” or “more than once a day” are deemed to be of clinical importance. A clinical cut-off is obtained if an individual has a score of three or more on at least one item within a subscale. | Item-level inter-rater and test-retest reliability and validity are good Spearman’s coefficients for inter-rater reliability range from .46 to .80 at item-level (73% > .60). Spearman’s coefficients for test-retest reliability range from .61 to .93 at item level (52.6% > .80). The scale has good concurrent validity and content validity between the RBQ and the repetitive subscale of the Autism Screening Questionnaire (ASQ [ |
| The Activity Questionnaire (TAQ) [ | The information-based questionnaire assesses behaviours that indicate overactivity and impulsivity and is suitable for use for people with ID. The questionnaire consists of 18 items grouped into three subscales: over-activity, impulsive speech and impulsivity. | The score range for over-activity is 0–36, impulsive speech 0–24 and impulsivity 0–24. Impulsive speech is not calculated for individuals who are non-verbal. Items are scored on a 5-point scale of “never/almost never” (0) to “always/almost all of the time” (5) to assess activity frequency. Scores of 32 for overactivity and 24 for impulsivity are identified as “abnormally high” (at or above the 95th percentile). | The scale has a good item level inter-rater reliability (mean of .56, range = .31 to.75) and test-retest reliability (mean of .75, range = .60 to .90). Inter-rater and test-retest reliability for subscales and total score were above .70 [ |
| Sensory Experience Questionnaire- Short form, Version 2.1 (SEQ) [ | The questionnaire examines the frequency of sensory behaviours across sensory response patterns (Hypo-Social, Hypo-Nonsocial, Hyper-Social and Hyper-Nonsocial), five sensory modalities (Tactile, Auditory, Visual, Gustatory, and Vestibular) and across social or non-social contexts. | The scale consists of 41 items (counting sub-items) rated on a 5-point scale of “almost never” (1) to “almost always” (5). A total score is obtained and sub-scores for sensory patterns (Hypo-responsiveness, Hyper-Responsiveness and Sensory Seeking), a score for each modality and for social and non-social contexts. A higher score is indicative of more severe sensory symptoms. | The overall internal consistency is |
| Health Questionnaire (HQ) [ | The questionnaire looks at the presence and subsequently the severity of 15 different health difficulties, with subsections assessing health difficulties over the entire lifetime and over the course of the last month. | The scale consists of 32 items. Severity of each reported health difficulty is rated on a 3-point scale of never (0) to severe (3). An overall health score is determined by summing the total for both time periods. A higher score indicates greater severity. | Inter-rater reliability for health difficulties reported across the individuals lifetime was |
Demographic characteristics and statistical analyses for participant groups: PTHS and matched AS and CdLS
| Demographic characteristic | PTHS, | AS, | CdLS, | Group comparison: chi-squared and Mann-Whitney | |||
|---|---|---|---|---|---|---|---|
| Comparison | |||||||
| Self-help scorea | Mean (SD) | 4.04 (.62) | 4.04 (.62) | 4 (.51) | PTHS ≈ AS | 288 | 1.00 |
| Median (IQR) | 4 (0) | 4 (0) | 4 (0) | PTHS ≈ CdLS | 287 | .967 | |
| Range | 3–6 | 3–6 | 3–5 | ||||
| Age | Mean (SD) | 11.2 (7.8) | 10.9 (7.3) | 11.3 (7.7) | PTHS ≈ AS | 282 | .901 |
| Median (IQR) | 8.5 (11) | 8.5 (11) | 9 (11) | PTHS ≈ CdLS | 285 | .951 | |
| Range | 1–30 | 2–27 | 1–30 | ||||
| Verbal (able to speak more than 30 signs/words) (%) | 2 (8.3) | 0 (0) | 1 (4.2) | PTHS ≈ AS | 2.09 | .490b | |
| PTHS ≈ CdLS | .356 | 1.00b | |||||
| Mobile (able to walk unaided) (%) | 11 (45.8) | 11 (45.8) | 16 (66.7) | PTHS ≈ AS | .000 | 1.00 | |
| PTHS ≈ CdLS | 2.12 | .146 | |||||
| % male | 50 | 47.8 | 41.7 | PTHS ≈ AS | .020 | .880 | |
| PTHS ≈ CdLS | .336 | .560 | |||||
| Visiona (categorised as “normal vision”) | 9 (37.5) | 20 (87) | 14 (60.9) | PTHS < AS | 12.16 | < .001 | |
| PTHS ≈ CdLS | 2.57 | .109 | |||||
| Hearinga (categorised as “normal hearing”) | 23 (95.8) | 24 (100) | 8 (34.8) | PTHS ≈ AS | 1.02 | 1.00b | |
| PTHS > CdLS | 19.50 | < .001 | |||||
IQR interquartile range
aDerived from the Wessex Scale [52]
bFishers exact p value reported as 50% had an expected count < 5
Health difficulties experienced by individuals with Pitt-Hopkins syndrome as taken from the Health Questionnaire
| Never/no | Mild | Moderate | Severe | Corrective surgery/treatment/medication? | ||
|---|---|---|---|---|---|---|
| Eye problems | Lifetime | 17 (70.8) | 2 (8.3) | 3 (12.5) | 2 (8.3) | 5 (71.4) |
| Last month | 23 (95.8) | 1 (4.2) | – | – | ||
| Ear problems | Lifetime | 12 (50) | 8 (33.3) | 3 (12.5) | 1 (4.2) | 4 (33.3) |
| Last month | 23 (95.8) | – | 1 (4.2) | – | ||
| Dental problems | Lifetime | 20 (83.3) | 1 (4.2) | 2 (8.3) | 1 (4.2) | 1 (25) |
| Last month | 23 (95.8) | 1 (4.2) | – | – | ||
| Cleft palate | Lifetime | 24 (100) | – | – | – | – |
| Last month | 23 (95.8) | 1 (4.2) | – | – | ||
| Gastrointestinal problems | Lifetime | 4 (16.7) | 9 (37.5) | 7 (29.2) | 4 (16.7) | 7 (35) |
| Last month | 11 (45.8) | 9 (37.5) | 3 (12.5) | 1 (4.2) | ||
| Bowel problems | Lifetime | 5 (20.8) | 14 (58.3) | 2 (8.3) | 3 (12.5) | 3 (15.8) |
| Last month | 13 (54.2) | 7 (29.2) | 3 (12.5) | 1 (4.2) | ||
| Heart abnormalities or circulatory problems | Lifetime | 22 (91.7) | 1 (4.2) | 1 (4.2) | – | – |
| Last month | 24 (100) | – | – | – | ||
| Problems with genitalia | Lifetime | 21 (87.5) | 1 (4.2) | 2 (8.3) | – | 2 (66.7) |
| Last month | 24 (100) | – | – | – | ||
| Hernia | Lifetime | 23 (95.8) | – | – | 1 (4.2) | 1 (100) |
| Last month | 23 (95.8) | 1 (4.2) | – | – | ||
| Limb abnormalities | Lifetime | 24 (100) | – | – | – | – |
| Last month | 24 (100) | – | – | – | ||
| Epilepsy/seizures | Lifetime | 12 (50) | 8 (33.3) | 4 (16.7) | – | 5 (41.7) |
| Last month | 20 (83.3) | 2 (8.3) | 2 (8.3) | – | ||
| Lung or respiratory problems | Lifetime | 20 (83.3) | 3 (12.5) | 1 (4.2) | – | 3 (75) |
| Last month | 24 (100) | – | – | – | ||
| Liver or kidney problems | Lifetime | 24 (100) | – | – | – | – |
| Last month | 24 (100) | – | – | – | ||
| Diabetes or thyroid function problems | Lifetime | 24 (100) | – | – | – | – |
| Last month | 24 (100) | – | – | – | ||
| Skin problems | Lifetime | 13 (54.2) | 7 (29.2) | 3 (12.5) | 1 (4.2) | 5 (45.5) |
| Last month | 16 (66.7) | 4 (16.7) | 4 (16.7) | – | ||
Median and interquartile ranges of ASD-related behaviours and percentage meeting criteria for ASD from the SCQ for participant groups: PTHS, AS and CdLS
| PTHS | AS | CdLS | Kruskal-Wallis tests/chi-squared test | Post hoc comparison: Mann-Whitney | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| h/ | df | Comparison | df |
| Effect size | ||||||||
| SCQ—total |
| 22 | 22 | 18 | |||||||||
| Median | 24 | 18 | 25 | 18.41 | 2 | < .001 | PTHS > AS | 73.50 | 1 | 3.965 | < .001 | 0.59 (large) | |
| IQR | 3.75 | 7 | 7.57 | ||||||||||
| SCQ—communication |
| 22 | 22 | 18 | |||||||||
| Median | 8 | 6 | 6.93 | 25.70 | 2 | < .001 | PTHS > AS | 55.00 | 1 | 4.555 | < .001 | 0.69 (large) | |
| IQR | 0.25 | 3 | 1.25 | ||||||||||
| SCQ—restricted, repetitive and stereotyped behaviours |
| 22 | 22 | 22 | |||||||||
| Median | 4 | 4 | 5 | 3.56 | 2 | .169 | N/A | ||||||
| IQR | 3 | 2.25 | 2.63 | ||||||||||
| SCQ—reciprocal social interaction |
| 22 | 22 | 18 | |||||||||
| Median | 10.5 | 7 | 12 | 11.15 | 2 | .004 | PTHS > AS | 132.00 | 1 | 2.598 | .009 | .39 (medium) | |
| IQR | 4.25 | 5.25 | 5.25 | ||||||||||
| Met ASD cut-off |
| 22 | 22 | 18 | |||||||||
| 21 (95.5) | 15 (68.2) | 16 (88.9) | 5.85 | 2 | .049a | PTHS > AS | 5.50 | 1 | – | .023 | 1.40 (1.04 to 1.89)b | ||
aFishers exact p value reported as 50% had an expected count < 5
bRelative risk of meeting criteria for ASD in AS relative to PTHS
Median and interquartile range for PTHS and comparison syndrome groups: AS and CdLS, derived from [31] and one-sample Wilcoxon test
| Median scores | PTHS ( | AS ( | CdLS ( | One-sample Wilcoxon test | |||||
|---|---|---|---|---|---|---|---|---|---|
| Comparison group [ |
| PTHS significance | Effect size | ||||||
| SQID familiar—total | Median (IQR) | 42.5 (15.25) | 53 (48–55) | 41.5 (35–48) | AS | 3.95 | < .001 | PTHS < AS | .57 (large) |
| CdLS | .360 | ||||||||
| SQID familiar—receive interaction | Median (IQR) | 11.5 (3) | 13 (12–14) | 10 (8.75–12) | AS | 3.21 | .001 | PTHS < AS | .46 (medium) |
| CdLS | 2.98 | .003 | PTHS > CdLS | .43 (medium) | |||||
| SQID familiar—interaction | Median (IQR) | 12 (4) | 13.5 (12–14) | 11 (10–13) | AS | 2.90 | .004 | PTHS < AS | .42 (medium) |
| CdLS | .072 | ||||||||
| SQID familiar—approach or initiate interaction | Median (IQR) | 8 (5) | 13 (10–14) | 10 (7–12) | AS | 4.21 | < .001 | PTHS < AS | .61 (large) |
| CdLS | 2.47 | .014 | PTHS < CdLS | .36 (medium) | |||||
| SQID familiar—performance | Median (IQR) | 12 (3) | 14 (12–14) | 11 (9–13) | AS | 3.83 | < .001 | PTHS < AS | .55 (large) |
| CdLS | .528 | ||||||||
| SQID unfamiliar—total | Median (IQR) | 35.5 (12.75) | 41 (31–48) | 26 (13.5–35) | AS | 2.88 | .004 | PTHS < AS | .42 (medium) |
| CdLS | 2.92 | .004 | PTHS > CdLS | .42 (medium) | |||||
| SQID unfamiliar—receive interaction | Median (IQR) | 9 (3) | 10 (8–12) | 6.5 (3–8) | AS | .108 | |||
| CdLS | 3.30 | .001 | PTHS > CdLS | .48 (medium) | |||||
| SQID unfamiliar—interaction | Median (IQR) | 9.5 (3) | 11 (9–12) | 7 (3–9) | AS | 3.03 | .002 | PTHS < AS | .44 (medium) |
| CdLS | 2.95 | .003 | PTHS > CdLS | .43 (medium) | |||||
| SQID unfamiliar—approach or initiate interaction | Median (IQR) | 6 (4.75) | 10 (6.75–12) | 5 (4–7.5) | AS | 3.72 | < .001 | PTHS < AS | .54 (large) |
| CdLS | 2.33 | .020 | PTHS > CdLS | .34 (medium) | |||||
| SQID unfamiliar—performance | Median (IQR) | 10 (3) | 10 (7–13) | 7 (2.75–9) | AS | .203 | |||
| CdLS | 2.16 | .031 | PTHS > CdLS | .31 (medium) | |||||
Median and interquartile ranges of behavioural characteristics, Kruskal-Wallis tests and post hoc Mann-Whitney U test analyses for participant groups: PTHS, AS and CdLS
| PTHS | AS | CdLS | Kruskal-Wallis tests | Post hoc comparison: Mann-Whitney | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| df | Comparison |
| df |
| Effect size | |||||||
| CBQ—Severity |
| 17 | 10 | 19 | |||||||||
| Median | 8 | 7 | 7 | 1.84 | 2 | .4 | N/A | ||||||
| IQR | 3 | 3.75 | 3 | ||||||||||
| MIPQ—Mood |
| 24 | 24 | 24 | |||||||||
| Median | 19 | 22 | 18 | 24.89 | 2 | < .001 | PTHS < AS | 105 | 1 | 3.819 | < .001 | .55 (large) | |
| IQR | 3.75 | 1 | 4.75 | ||||||||||
| MIPQ—Interest and Pleasure |
| 24 | 24 | 24 | |||||||||
| Median | 17 | 17.5 | 15 | 2.07 | 2 | .356 | N/A | ||||||
| IQR | 4.75 | 5.5 | 4.75 | ||||||||||
| MIPQ—Total |
| 24 | 24 | 24 | |||||||||
| Median | 36 | 39.5 | 34 | 9.87 | 2 | .007 | PTHS < AS | 185.5 | 1 | 2.121 | .034 | .31 (medium) | |
| IQR | 3.75 | 7 | 8.75 | ||||||||||
| RBQ—Total |
| 22 | 23 | 22 | |||||||||
| Median | 12 | 12 | 16.5 | 4.34 | 2 | .114 | N/A | ||||||
| IQR | 6.5 | 10 | 24 | ||||||||||
| RBQ—Stereotyped Behaviour |
| 24 | 23 | 24 | |||||||||
| Median | 10.5 | 8 | 9.5 | 2.85 | 2 | .241 | N/A | ||||||
| IQR | 4.5 | 8 | 6 | ||||||||||
| RBQ—Compulsive Behaviour |
| 24 | 23 | 24 | |||||||||
| Median | 0 | 0 | 0 | 4.23 | 2 | .121 | N/A | ||||||
| IQR | 0 | 1 | 9.75 | ||||||||||
| RBQ—Insistence on Sameness |
| 24 | 24 | 23 | |||||||||
| Median | 0 | 0 | 0 | 1.39 | 2 | .499 | N/A | ||||||
| IQR | 3 | 1 | 6 | ||||||||||
| TAQ—Impulsivity |
| 24 | 24 | 23 | |||||||||
| Median | 15.5 | 18 | 15 | .552 | 2 | .759 | N/A | ||||||
| IQR | 9.75 | 13.5 | 11 | ||||||||||
| TAQ—Overactivity |
| 24 | 24 | 23 | |||||||||
| Median | 18 | 19.5 | 19 | .618 | 2 | .734 | N/A | ||||||
| IQR | 8.75 | 14 | 13 | ||||||||||
| TAQ—Total |
| 24 | 24 | 23 | |||||||||
| Median | 33.75 | 35 | 32.5 | .347 | 2 | .841 | N/A | ||||||
| IQR | 15.25 | 22.9 | 25.8 | ||||||||||
Number and percentage of individuals with PTHS and matched AS and CdLS displaying challenging behaviour and chi-squared analysis
| PTHS, | AS, | CdLS, | Chi-squared test | Post hoc comparison: chi-squared test | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
| df | Comparison |
| df | Relative risk (95% CI) | ||||||
| Displayed SIB in the last month (%) | 17 (70.8%) | 10 (41.7%) | 19 (79.2%) | 8.07 | 2 | .018 | PTHS > AS | 4.15 | 1 | .042 | 1.70 (.99 to 2.91)a |
| Displayed destruction of property in the last month (%) | 9 (37.5%) | 13 (54.2%) | 13 (54.2%) | 1.78 | 2 | .411 | |||||
| Displayed physical aggression in the last month (%) | 13 (54.2%) | 16 (66.7%) | 6 (25%) | 8.79 | 2 | .012 | PTHS > CdLS | 4.27 | 1 | .039 | 2.17 (.99 to 4.75)b |
| Displayed stereotyped behaviour in the last month (%) | 18 (75%) | 16 (66.7%) | 21 (87.5%) | 2.93 | 2 | .232 | |||||
aRelative risk of self-injurious behaviour in AS relative to PTHS
bRelative risk of physical aggression in CdLS relative to PTHS
Number and percentage of individuals with PTHS scoring within the atypical range on the SEQ
| PTHS, | ||
|---|---|---|
| Total SEQ | Median (IQR) | 86.5 (15.98) |
| 23 (95.80) | ||
| Classification | At risk | |
| Hypo-responsiveness | Median (IQR) | 16.5 (6.25) |
| 23 (95.80) | ||
| Classification | Deficient | |
| Hyper-responsiveness | Median (IQR) | 31.2 (11.58) |
| 15 (62.50) | ||
| Classification | At risk | |
| Sensory-seeking | Median (IQR) | 42 (5.75) |
| 18 (75) | ||
| Classification | At risk | |
| Social contexts | Median (IQR) | 23.5 (7.25) |
| 22 (91.70) | ||
| Classification | Deficient | |
| Non-social contexts | Median (IQR) | 61.3 (11.50) |
| 18 (75) | ||
| Classification | At risk | |
Criterion cut-off points based on typically developing normative data [56]
Total: typical range (33–74), at risk range (75–86) and deficient range (87–165). Hypo-responsitivity: typical range (6–10), at risk range (11–12) and deficient range (13–30). Hyper-responsitivity: typical range (14–29), at risk range (30–34) and deficient range (35–70). Sensory seeking: typical range (13–38), at risk range (39–47) and deficient range (48–65). Social contexts: typical range (10–18), at risk range (19–21) and deficient range (22–50). Non-social contexts: typical range (22–55), at risk range (56–65) and deficient range (66–11)